Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2018-11-26 Investor Presentation
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
107年11月法人說明會簡報 — 316420181126M001.ppt
Investor Presentation Classification · 93% confidence The document is a slide deck with market outlook, product pipeline, R&D achievements, patent and clinical trial highlights, financial status tables, and risk assessment – all hallmarks of an Investor Presentation. It is not a regulatory filing or a formal annual or interim report, but a presentation prepared for investors. Therefore it should be classified as an Investor Presentation (IP).
2018-11-26 Chinese
107年11月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing of scheduled investor presentations (法人說明會) with details such as company code, name, date, time, location, and links to presentation files. It does not contain financial statements or detailed financial analysis but rather information about investor meetings and presentation materials. This matches the definition of an Investor Presentation (IP). The document length is short and it is not an announcement of a report publication but the actual presentation schedule and materials. Therefore, the correct classification is Investor Presentation (IP).
2018-11-26 Chinese
本公司受邀參加永豐金證券舉辦之法人說明會
Investor Presentation Classification · 95% confidence The document is a brief announcement about the company (3164 景岳) being invited to participate in an investor presentation hosted by 永豐金證券. It includes details such as the date, time, and location of the investor presentation and a summary that the company will explain its business operations. The document is short (649 characters) and does not contain any financial statements or detailed financial data. It is clearly an announcement of an upcoming investor presentation event rather than the presentation itself or a financial report. Therefore, the appropriate classification is Investor Presentation (IP).
2018-11-26 Chinese
107年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes details such as capital amounts, investment methods, cumulative investment funds remitted, shareholding percentages, and recognized investment gains or losses. The document also references regulatory limits and approvals by the Economic Ministry Investment Commission. The content is specific to investment disclosures rather than a full financial report or earnings release. The document length is short (1308 characters) and it is a regulatory disclosure of investment information, not a full report or announcement of a report. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2018-11-14 Chinese
107年第3季財務報告書 — 201804_3164_AI3.pdf
Regulatory Filings
2018-11-13 Chinese
107年第3季財務報告書 — 201804_3164_AI1.pdf
Regulatory Filings
2018-11-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.